US 11208493
Internalizing human monoclonal antibodies targeting prostate and other cancer cells
granted A61KA61K47/6811A61K47/6829
Quick answer
US patent 11208493 (Internalizing human monoclonal antibodies targeting prostate and other cancer cells) held by The Regents of the University of California expires Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Dec 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K47/6811, A61K47/6829, A61K47/6849, A61K47/6869